Teva stock downgraded to neutral by UBS on heels of $85 million opioid settlement - MarketWatch
Teva reports jump in first-quarter earnings, raises guidance | The Times of Israel
Sex, drugs, and sharing trade secrets
Israeli drugmaker Teva to cut quarter of global work force (Update)
EU fines drug makers for keeping cheap medicine off market
Teva to cut 14,000 jobs | Business | Chemistry World
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Teva Pharmaceutical: Slow Road To A Higher Share Price (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment | Seeking Alpha
Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
Teva Pharmaceuticals considers laying-off 10,000 workers - The Jerusalem Post
Teva Pharmaceutical Launches First Generic Formulation of Gilead's Blockbuster Antiretroviral Truvada
Teva Pharmaceuticals - Generic and Specialty Pharmaceuticals | Start-Up Nation Finder
Teva's Blockbuster Drug Takes Another Generic Blow | Ctech
Teva Pharmaceutical Stock Could Double | Barron's
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll | Fierce Pharma
Teva Pharmaceutical Stock: Gem Among Generic Pharma Companies (NYSE:TEVA) | Seeking Alpha
Pfizer Wins $2.15B Patent Suit with Teva, Sun Pharma | Fox Business
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Migraine treatment results in Japan boost Teva - Globes
Teva seeks blockbuster drug to succeed Copaxone - Globes
